A double-negative feedback loop between ZEB1-SIP1 and the microRNA-200 family regulates epithelial-mesenchymal transition - PubMed (original) (raw)
A double-negative feedback loop between ZEB1-SIP1 and the microRNA-200 family regulates epithelial-mesenchymal transition
Cameron P Bracken et al. Cancer Res. 2008.
Abstract
Epithelial to mesenchymal transition occurs during embryologic development to allow tissue remodeling and is proposed to be a key step in the metastasis of epithelial-derived tumors. The miR-200 family of microRNAs plays a major role in specifying the epithelial phenotype by preventing expression of the transcription repressors, ZEB1/deltaEF1 and SIP1/ZEB2. We show here that miR-200a, miR-200b, and the related miR-429 are all encoded on a 7.5-kb polycistronic primary miRNA (pri-miR) transcript. We show that the promoter for the pri-miR is located within a 300-bp segment located 4 kb upstream of miR-200b. This promoter region is sufficient to confer expression in epithelial cells and is repressed in mesenchymal cells by ZEB1 and SIP1 through their binding to a conserved pair of ZEB-type E-box elements located proximal to the transcription start site. These findings establish a double-negative feedback loop controlling ZEB1-SIP1 and miR-200 family expression that regulates cellular phenotype and has direct relevance to the role of these factors in tumor progression.
Similar articles
- The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1.
Gregory PA, Bert AG, Paterson EL, Barry SC, Tsykin A, Farshid G, Vadas MA, Khew-Goodall Y, Goodall GJ. Gregory PA, et al. Nat Cell Biol. 2008 May;10(5):593-601. doi: 10.1038/ncb1722. Epub 2008 Mar 30. Nat Cell Biol. 2008. PMID: 18376396 - The microRNA-200 family regulates epithelial to mesenchymal transition.
Paterson EL, Kolesnikoff N, Gregory PA, Bert AG, Khew-Goodall Y, Goodall GJ. Paterson EL, et al. ScientificWorldJournal. 2008 Sep 21;8:901-4. doi: 10.1100/tsw.2008.115. ScientificWorldJournal. 2008. PMID: 18836656 Free PMC article. - Differential regulation of epithelial and mesenchymal markers by deltaEF1 proteins in epithelial mesenchymal transition induced by TGF-beta.
Shirakihara T, Saitoh M, Miyazono K. Shirakihara T, et al. Mol Biol Cell. 2007 Sep;18(9):3533-44. doi: 10.1091/mbc.e07-03-0249. Epub 2007 Jul 5. Mol Biol Cell. 2007. PMID: 17615296 Free PMC article. - MicroRNAs as regulators of epithelial-mesenchymal transition.
Gregory PA, Bracken CP, Bert AG, Goodall GJ. Gregory PA, et al. Cell Cycle. 2008 Oct;7(20):3112-8. doi: 10.4161/cc.7.20.6851. Epub 2008 Oct 25. Cell Cycle. 2008. PMID: 18927505 Review. - ZEB/miR-200 feedback loop: at the crossroads of signal transduction in cancer.
Hill L, Browne G, Tulchinsky E. Hill L, et al. Int J Cancer. 2013 Feb 15;132(4):745-54. doi: 10.1002/ijc.27708. Epub 2012 Jul 21. Int J Cancer. 2013. PMID: 22753312 Review.
Cited by
- MicroRNA-98 as a novel diagnostic marker and therapeutic target in cancer patients.
Akhlaghipour I, Moghbeli M. Akhlaghipour I, et al. Discov Oncol. 2024 Aug 29;15(1):385. doi: 10.1007/s12672-024-01270-z. Discov Oncol. 2024. PMID: 39210158 Free PMC article. Review. - Overexpression of miR-200s inhibits proliferation and invasion while increasing apoptosis in murine ovarian cancer cells.
Carter R, Petrik JJ, Moorehead RA. Carter R, et al. PLoS One. 2024 Jul 19;19(7):e0307178. doi: 10.1371/journal.pone.0307178. eCollection 2024. PLoS One. 2024. PMID: 39028700 Free PMC article. - miR-617 interacts with the promoter of DDX27 and positively regulates its expression: implications for cancer therapeutics.
Sarkar N, Mishra R, Gopal C, Kumar A. Sarkar N, et al. Front Oncol. 2024 Jun 13;14:1411539. doi: 10.3389/fonc.2024.1411539. eCollection 2024. Front Oncol. 2024. PMID: 38939334 Free PMC article. - TWIST1 Drives Cytotoxic CD8+ T-Cell Exhaustion through Transcriptional Activation of CD274 (PD-L1) Expression in Breast Cancer Cells.
Yu X, Xu J. Yu X, et al. Cancers (Basel). 2024 May 22;16(11):1973. doi: 10.3390/cancers16111973. Cancers (Basel). 2024. PMID: 38893094 Free PMC article. - IRTKS contributes to the malignant progression of cervical cancer cells.
Zhang Y, Yi F, Zhang X, Song J, Cai J, Lai J, Song F. Zhang Y, et al. Med Oncol. 2024 Jun 13;41(7):174. doi: 10.1007/s12032-024-02410-9. Med Oncol. 2024. PMID: 38869721
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials